Connect with us

Health & Fitness

AstraZeneca Vaccine Unfairly Under Fire Over Clot Risk?

(MedPage Today) — Thromboembolic and bleeding risk has been cited by a number of countries in halting use of AstraZeneca’s COVID-19 vaccine, but the company and health agencies argued against a causal link. Denmark and Norway were first to stop…

Published

on

AstraZeneca Vaccine Unfairly Under Fire Over Clot Risk?